Cyclerion Therapeutics, Inc(NASDAQ:CYCN) 
Cyclerion Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovering, development, and commercialization of medicines for serious central nervous system (CNS) diseases. Its product candidates include CY6463, a CNS-penetrant, soluble guanylate cyclase (sGC) stimulator ...
Website: http://www.cyclerion.com
Founded: 2018
Full Time Employees: 94
CEO: Peter M. Hecht
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 2.49
H 2.61
L 2.40
C 2.50
V 14,607
10EMA 2.50
20EMA 2.50
60EMA 2.50
120EMA 2.50
250EMA 2.50